US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
ChemoCentryx Inc (CCXI)
ChemoCentryx Inc (CCXI) ニュース

CCXI

ChemoCentryx (CCXI)

ChemoCentryx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CCXI

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/10/25	08 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	08 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	07 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	07 : 58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/25	07 : 58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/20	22 : 28	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/20	22 : 27	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/20	22 : 27	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/20	22 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/20	22 : 05	PR Newswire (US)	AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/20	21 : 41	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/19	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/17	21 : 30	GlobeNewswire Inc.	ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/08	05 : 36	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CCXI	ChemoCentryx Inc
2022/10/05	21 : 30	GlobeNewswire Inc.	ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:CCXI	ChemoCentryx Inc
2022/09/20	19 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CCXI	ChemoCentryx Inc
2022/09/20	19 : 03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CCXI	ChemoCentryx Inc
2022/09/15	06 : 32	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:CCXI	ChemoCentryx Inc
2022/09/13	00 : 14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CCXI	ChemoCentryx Inc
2022/09/01	06 : 08	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	NASDAQ:CCXI	ChemoCentryx Inc
2022/08/24	21 : 30	GlobeNewswire Inc.	ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences	NASDAQ:CCXI	ChemoCentryx Inc
2022/08/23	19 : 02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CCXI	ChemoCentryx Inc
2022/08/19	05 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CCXI	ChemoCentryx Inc
2022/08/10	05 : 13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CCXI	ChemoCentryx Inc

Showing the most relevant articles for your search:NASDAQ:CCXI

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Deutsche Telekom (QX)

Bank of America

Verizon Communications

BNP Paribas (QX)

US Dollar vs Yen

US Dollar vs Euro

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約